Skip to main content
Contact Us
Subscribe
E-Edition
52°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Entertainment
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about IPSEY
Recent news which mentions IPSEY
Why These Two Biotech Stocks Blasted Higher This Week
January 13, 2023
Tickers
ALBO
AZN
CINC
IPSEY
Tags
ALBO
AZN
Market News
From
Motley Fool
2 Tiny Nasdaq Stocks Making Major Merger Moves Monday
January 09, 2023
Tickers
ALBO
DCT
IPSEY
Tags
ALBO
DCT
Market News
From
Motley Fool
France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline
January 09, 2023
Tickers
ALBO
IPSEF
IPSEY
Tags
News
Eurasia
ALBO
From
Benzinga
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
December 09, 2022
Tickers
EXEL
IPSEY
RHHBY
TAK
Tags
Market News
EXEL
RHHBY
From
Benzinga
Why Merrimack Shares Are Surging Over 200% Today?
November 09, 2022
Tickers
IPSEF
IPSEY
MACK
Tags
Trading Ideas
premarket trading
News
From
Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
Tickers
APLS
ARDX
AZN
FOLD
Tags
SPPI
VERU
News
From
Benzinga
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
October 02, 2022
Tickers
ALNY
AMLX
AZN
BLUE
Tags
SPPI
RVNC
News
From
Benzinga
Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases
September 19, 2022
Tickers
GNFT
IPSEY
Tags
Trading Ideas
M&A
Eurasia
From
Benzinga
Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure
August 03, 2022
Tickers
IPSEF
IPSEY
MACK
Tags
Trading Ideas
News
Movers
From
Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
June 28, 2022
Tickers
AFIB
AGRX
AGTC
AMST
Tags
SRRK
SHCR
PETV
From
Benzinga
Why Adaptimmune Therapeutics Stock Is Popping Today
June 27, 2022
Tickers
ADAP
EPZM
IPSEY
Tags
IPSEY
Recent Press Releases
Market News
From
Motley Fool
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
June 27, 2022
Tickers
AFIB
AGRX
AGTC
ARMP
Tags
EAR
RGS
Small Cap
From
Benzinga
Why Epizyme Stock Is Soaring Today
June 27, 2022
Tickers
EPZM
IPSEY
Tags
IPSEY
Recent Press Releases
Market News
From
Motley Fool
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Tickers
ALPMF
ALPMY
AXSM
AZN
Tags
AZN
DSNKY
NUVB
From
Benzinga
Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why
June 27, 2022
Tickers
EPZM
IPSEF
IPSEY
Tags
Trading Ideas
M&A
News
From
Benzinga
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
May 17, 2022
Tickers
BMY
ETSY
EXEL
IPSEY
Tags
EXEL
Market News
ETSY
From
Motley Fool
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Tickers
ACAD
AQST
BIIB
BLTE
Tags
OCUL
BLTE
News
From
Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
May 03, 2022
Tickers
EXEL
IPSEF
IPSEY
Tags
Health Care
Market News
EXEL
From
Benzinga
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
March 25, 2022
Tickers
EXEL
IPSEF
IPSEY
Tags
IPSEY
Biotech
General
From
Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Tickers
BAYRY
BAYZF
EXEL
IPSEY
Tags
News
RHHBF
BAYZF
From
Benzinga
A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge
January 24, 2022
Tickers
ABBV
GILD
HAL
IBM
Tags
IBM
PFE
HAL
From
Benzinga
Ipsen's Sohonos Scores Canadian Approval For Rare Connective Tissue Disease
January 24, 2022
Tickers
IPSEF
IPSEY
Tags
Biotech
Briefs
IPSEY
From
Benzinga
GNFT Stock Alert: 15 Things to Know About Biotech Penny Stock Genfit as Shares Go Gangbusters
December 17, 2021
Tickers
BABA
FUTU
GNFT
IPSEY
Tags
NVAX
NASDAQ:GNFT,OTCMKTS:IPSEY,NYSE:BABA,NASDAQ:NVAX,NASDAQ:FUTU
Market News
From
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 17, 2021
Tickers
ABEO
ADGI
BLIN
CERN
Tags
SPRB
KXIN
Today's Market
From
InvestorPlace
Genfit Shares Rally After Ipsen Buys Rights To Its Late-Stage Kidney Disease Treatment Hopeful
December 17, 2021
Tickers
GNFT
IPSEF
IPSEY
Tags
Trading Ideas
Long Ideas
News
From
Benzinga
Ipsen Stock Declines After Pulling Rare Disease Application
August 13, 2021
Tickers
IPSEF
IPSEY
Tags
News
New Drug Application
Trading Ideas
From
Benzinga
Exicure Stock Surges On Over $1B Option Licensing Pact With Ipsen For Rare Neurodegenerative Disorders
August 02, 2021
Tickers
IPSEF
IPSEY
XCUR
Tags
News
XCUR
Long Ideas
From
Benzinga
Ipsen Beefs Up Pre-Clinical Oncology Pipeline With Over $850M Deal With BAKX Therapeutics
July 27, 2021
Tickers
IPSEF
IPSEY
Tags
News
Benzinga
General
From
Benzinga
Ipsen In-Licenses Parkinson's Candidate From IRLAB
July 15, 2021
Tickers
IPSEY
Tags
News
Contracts
General
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.